Delivery Order SPE2DB22D1017-SPE2DB23FG2NT
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $23,133 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania. Funding comes from the Defense Logistics Agency in support of Department of Defense procurement and readiness programs. Amerisourcebergen will serve as the...
- The Defense Logistics Agency awarded a $30,635.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order is against an existing prime vendor contract held by Amerisourcebergen to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three day period from July 3, 2023 through July 5, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $33,579.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The order is for 2,000 syringes to be delivered to a facility in Conshohocken, Pennsylvania by September 6, 2023. Amerisourcebergen will fulfill the order under an existing Prime Vendor Next Generation contract vehicle with the Defense Logistics Agency. No subcontractors or set aside designations were specified. The delivery order supports the...
- The Defense Logistics Agency awarded a $18,957.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by July 17, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $15,146.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the syringes to a location in Conshohocken, Pennsylvania by September 1, 2023 to support DLA's mission to provide medical supplies and logistics...
- The Defense Logistics Agency awarded a $25,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The order is associated with DLA's prime vendor program and supports the Department of Defense's medical supply needs. Amerisourcebergen will deliver the syringes to its facility in Conshohocken, Pennsylvania by September 7th to fulfill requirements under the agency's pharmaceutical contracts. No set aside provisions or subcontractors are...
- The Defense Logistics Agency awarded a $21,030 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The firm fixed price order is for a single day of performance in Conshohocken, Pennsylvania and was awarded under an unspecified multiple award contract vehicle. DLA will provide funding for 2,000 ML of the injectable drug to support the Department of Defense's medical readiness programs. Amerisourcebergen will fulfill the order without use of major...
- The Defense Logistics Agency awarded a $6,609 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 200 MG/1.14 ML SYRING 1.14ML. The firm fixed price order is being fulfilled under an existing DLA contract vehicle and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania over a one day period concluding on August 16, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the injectable drug DUPIXENT aligns with...
- The Defense Logistics Agency awarded a $5,139.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561740030 DUPIXENT 300 MG/2 ML SYRINGE 2ML. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 8 to August 9, 2023. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,652 to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The contract has a period of performance from July 19, 2023 through July 20, 2023. Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs. No set aside provisions or subcontractors were identified. The...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG2NTDelivery Order
The Defense Logistics Agency awarded a $3,450.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML syringes. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 30 to August 31, 2023. The delivery order was competitively awarded utilizing commercial item procedures with no set-aside designation. Amerisourcebergen will fulfill the order directly as prime contractor to supply the specified drug to DLA, likely in support of DOD medical treatment facilities and their patients.
Generated 12/23/23, 2:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/30/23 |